SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* SAINTS CAPITAL GRANITE, L.P. (Last) (First) (Middle) C/O SAINTS CAPITAL SERVICES, LLC 475 SANSOME STREET, SUITE 1850 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol ENANTA PHARMACEUTICALS INC [ ENTA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 03/26/2013
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/26/2013		P		66,474(1)	A	$14	102,176	I	By Funds(2)
Common Stock	03/26/2013		C		621,262	A	(3)	723,438	I	By Funds(2)
Common Stock	03/26/2013		C		924,523	A	(5)	1,647,961	I	By Funds(2)
Common Stock	03/26/2013		C		424,014	A	(7)	2,071,975	I	By Funds(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series D Convertible Preferred Stock	(3)	03/26/2013		C			2,000,000(3)	(3)	(3)	Common Stock	621,262(4)	$0	0	I	By Funds(2)
Series E Convertible Preferred Stock	(5)	03/26/2013		C			3,028,374(5)	(5)	(5)	Common Stock	924,523(6)	$0	0	I	By Funds(2)
Series G-2 Convertible Preferred Stock	(7)	03/26/2013		C			1,827,508(7)	(7)	(7)	Common Stock	424,014(8)	$0	0	I	By Funds(2)

1. Name and Address of Reporting Person* SAINTS CAPITAL GRANITE, L.P. (Last) (First) (Middle) C/O SAINTS CAPITAL SERVICES, LLC 475 SANSOME STREET, SUITE 1850 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Saints Capital Granite, LLC (Last) (First) (Middle) 475 SANSOME STREET SUITE 1850 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* mRNA - Holdings LLC (Last) (First) (Middle) 475 SANSOME STREET SUITE 1850 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* OBP (Adjunct) III - Holdings LLC (Last) (First) (Middle) 475 SANSOME STREET SUITE 1850 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* OBP (Bermuda) III - Holdings LLC (Last) (First) (Middle) 475 SANSOME STREET SUITE 1850 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* OBP III - Holdings LLC (Last) (First) (Middle) 475 SANSOME STREET SUITE 1850 (Street) SAN FRANCISCO CA 94111 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. This share number consists of (i) 628 shares of Common Stock owned directly by mRNA - Holdings LLC ("mRNA"), (ii) 5,589 shares of Common Stock owned directly by OBP (Adjunct) III - Holdings LLC ("OBP (A) III"), (iii) 7,513 shares of Common Stock owned directly by OBP (Bermuda) III - Holdings LLC ("OBP (B) III") and (iv) 52,744 shares of Common Stock owned directly by OBP III - Holdings LLC ("OBP III", and together with mRNA, OBP (A) III, and OBP (B) III, the "Funds").

2. Saints Capital Granite, L.P. ("Saints LP") is a member of each of the Funds and has voting and investment control with respect to the securities owned directly by the Funds. Saints Capital Granite, LLC ("Saints LLC") is the general partner of Saints LP. Saints LP disclaims beneficial ownership of the securities owned directly by the Funds, except to the extent of any pecuniary interest therein, if any, by virtue of its membership interest in the Funds. Saints LLC disclaims beneficial ownership of the securities owned directly by the Funds, except to the extent of any pecuniary interest therein, if any, by virtue of its general partner interests in Saints LP.

3. The Series D Convertible Preferred Stock has no expiration date and each share of Series D Convertible Preferred Stock converted automatically into approximately 0.31063 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration.

4. This share number consists of (i) 5,851 shares of Common Stock underlying shares of Series D Convertible Preferred Stock owned directly by mRNA, (ii) 46,594 shares of Common Stock underlying shares of Series D Convertible Preferred Stock owned directly by OBP (A) III, (iii) 70,955 shares of Common Stock underlying shares of Series D Convertible Preferred Stock owned directly by OBP (B) III and (iv) 497,862 shares of Common Stock underlying shares of Series D Convertible Preferred Stock owned directly by OBP III.

5. The Series E Convertible Preferred Stock has no expiration date and each share of Series E Convertible Preferred Stock converted automatically into approximately 0.30529 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration.

6. This share number consists of (i) 8,699 shares of Common Stock underlying shares of Series E Convertible Preferred Stock owned directly by mRNA, (ii) 78,319 shares of Common Stock underlying shares of Series E Convertible Preferred Stock owned directly by OBP (A) III, (iii) 104,472 shares of Common Stock underlying shares of Series E Convertible Preferred Stock owned directly by OBP (B) III and (iv) 733,033 shares of Common Stock underlying shares of Series E Convertible Preferred Stock owned directly by OBP III.

7. The Series G-2 Convertible Preferred Stock has no expiration date and each share of Series G-2 Convertible Preferred Stock converted automatically into approximately 0.23202 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration.

8. This share number consists of (i) 4,041 shares of Common Stock underlying shares of Series G-2 Convertible Preferred Stock owned directly by mRNA, (ii) 35,064 shares of Common Stock underlying shares of Series G-2 Convertible Preferred Stock owned directly by OBP (A) III, (iii) 47,939 shares of Common Stock underlying shares of Series G-2 Convertible Preferred Stock owned directly by OBP (B) III and (iv) 336,970 shares of Common Stock underlying shares of Series G-2 Convertible Preferred Stock owned directly by OBP III.

	Saints Capital Granite, L.P., By: Saints Capital Granite, LLC, its General Partner, By: /s/ Scott Halsted, Managing Member	03/28/2013
	Saints Capital Granite, LLC, By: /s/ Scott Halsted, Managing Member	03/28/2013
	mRNA - Holdings LLC, By: /s/ Scott Halsted, Scott Halsted, Managing Member of, Saints Capital Granite, LLC, General Partner of Saint Capital Granite, L.P., a Member of mRNA - Holdings LLC	03/28/2013
	OBP (Adjunct) III - Holdings LLC, By: /s/ Scott Halsted, Scott Halsted, Managing Member of, Saints Capital Granite, LLC, General Partner of, Saint Capital Granite, L.P., a Member of, OBP (Adjunct) III - Holdings LLC	03/28/2013
	OBP (Bermuda) III - Holdings LLC, By: /s/ Scott Halsted, Scott Halsted, Managing Member of Saints Capital, Granite, LLC, General Partner of, Saint Capital Granite, L.P., a Member of, OBP (Bermuda) III - Holdings LLC	03/28/2013
	OBP III - Holdings LLC, By: /s/ Scott Halsted, Scott Halsted, Managing Member of Saints Capital, Granite, LLC, General Partner of Saint Capital, Granite, L.P., a Member of, OBP III - Holdings LLC	03/28/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.